Metastatic Angiosarcoma
3 clinical trials · Condition
◉ Watch Metastatic Angiosarcoma
| Record | Firm | Date |
|---|---|---|
| Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study (NCT05026736) | M.D. Anderson Cancer Center | 2021-08-23 |
| Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma (NCT04668300) | M.D. Anderson Cancer Center | 2020-11-26 |
| Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery (NCT03009201) | OHSU Knight Cancer Institute | 2017-03-10 |
Track Metastatic Angiosarcoma automatically
Every clearance here is in the API, with alerts when new ones post.